tiprankstipranks
Trending News
More News >
Mayne Pharma Group Ltd. (AU:MYX)
:MYX
Australian Market
Advertisement

Mayne Pharma Group (MYX) Income Statement

Compare
44 Followers

Mayne Pharma Group Income Statement

Last quarter (Q4 2025), Mayne Pharma Group's total revenue was AU$195.04M, an increase of 136.64% from the same quarter last year. In Q4, Mayne Pharma Group's net income was AU$-68.29M. See Mayne Pharma Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 408.10MAU$ 388.15MAU$ 183.59MAU$ 157.15MAU$ 400.78M
Gross Profit
AU$ 247.27MAU$ 218.53MAU$ 26.84MAU$ 23.75MAU$ 127.02M
Operating Expenses
AU$ 270.87MAU$ 357.59MAU$ 213.28MAU$ 145.62MAU$ 125.65M
Depreciation and Amortization
AU$ 64.11MAU$ 68.46MAU$ 65.44MAU$ 55.18MAU$ 68.19M
EBITDA
AU$ 42.08MAU$ -116.93MAU$ -193.80MAU$ -78.88MAU$ -182.40M
Operating Income
AU$ -23.59MAU$ -139.06MAU$ -186.44MAU$ -121.88MAU$ 1.36M
Other Income/Expenses
AU$ -59.70MAU$ -51.02MAU$ -83.25MAU$ -23.71MAU$ -265.25M
Pretax Income
AU$ -83.30MAU$ -190.09MAU$ -269.70MAU$ -145.59MAU$ -263.89M
Net Income
AU$ -93.84MAU$ -174.23MAU$ 117.25MAU$ -281.29MAU$ -208.42M
Per Share Metrics
Basic EPS
AU$ -1.14AU$ -2.19AU$ -3.89AU$ -3.46AU$ -2.57
Diluted EPS
AU$ -1.14AU$ -2.19AU$ -3.89AU$ -3.46AU$ -2.57
Weighted Average Shares Outstanding
82.31M 79.62M 81.25M 81.25M 81.25M
Weighted Average Shares Outstanding (Diluted)
79.14M 79.62M 81.25M 81.25M 81.25M
Currency in AUD

Mayne Pharma Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis